Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Gedeon Richter Sees Profit Jump By 40%
Driven By Strong Vraylar Tailwind As Cariprazine Brand Beats Expectations
Feb 21 2020
•
By
Penelope MacRae
Gedeon Richter has seen its net profit leap by 40% • Source: Shutterstock
More from Earnings
More from Business